Stevens Capital Management’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-6,486
| Closed | -$350K | – | 727 |
|
|
2017
Q4 | $350K | Buy |
6,486
+2,660
| +70% | +$144K | 0.01% | 626 |
|
|
2017
Q3 | $222K | Buy |
+3,826
| New | +$222K | 0.01% | 738 |
|
|
2017
Q2 | – | Sell |
-9,821
| Closed | -$427K | – | 840 |
|
|
2017
Q1 | $427K | Buy |
+9,821
| New | +$427K | 0.02% | 617 |
|
|
2016
Q1 | – | Sell |
-10,467
| Closed | -$399K | – | 870 |
|
|
2015
Q4 | $399K | Sell |
10,467
-2,826
| -21% | -$108K | 0.02% | 613 |
|
|
2015
Q3 | $423K | Buy |
13,293
+4,946
| +59% | +$157K | 0.02% | 587 |
|
|
2015
Q2 | $276K | Buy |
+8,347
| New | +$276K | 0.01% | 774 |
|
|
2014
Q3 | – | Sell |
-11,026
| Closed | -$511K | – | 981 |
|
|
2014
Q2 | $511K | Buy |
11,026
+2,912
| +36% | +$135K | 0.01% | 655 |
|
|
2014
Q1 | $333K | Buy |
+8,114
| New | +$333K | 0.01% | 762 |
|